Matthew Harrison
Stock Analyst at Morgan Stanley
(3.29)
# 931
Out of 4,829 analysts
737
Total ratings
45.64%
Success rate
1.19%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Overweight | $182 → $113 | $36.27 | +211.55% | 36 | May 7, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $462 → $464 | $424.99 | +9.18% | 38 | May 6, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $130 → $135 | $96.91 | +39.30% | 41 | Apr 25, 2025 | |
| AVIR Atea Pharmaceuticals | Maintains: Equal-Weight | $6.2 → $6 | $2.72 | +120.59% | 10 | Apr 11, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $157 → $152 | $118.17 | +28.63% | 52 | Apr 9, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $39 → $32 | $24.25 | +31.96% | 25 | Apr 9, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $82 → $80 | $31.78 | +151.73% | 11 | Mar 17, 2025 | |
| TSVT 2seventy bio | Maintains: Equal-Weight | $6 → $5 | $4.99 | +0.20% | 10 | Mar 14, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Overweight | $15 → $5 | $0.41 | +1,108.02% | 5 | Mar 12, 2025 | |
| DNLI Denali Therapeutics | Assumes: Overweight | $41 → $33 | $14.37 | +129.65% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $136.52 | +30.38% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $36.80 | +52.17% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $90 | $65.08 | +38.29% | 16 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $34.25 | +60.58% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.17 | +156.41% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1,235 → $1,184 | $527.78 | +124.34% | 50 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $1.00 | +500.00% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $12.30 | -10.57% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.23 | +550.41% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $549.27 | -7.15% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.45 | +382.76% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $58.86 | +90.28% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $16.60 | +104.82% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $19.36 | +65.29% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $1.30 | +1,361.54% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $60 | $3.50 | +1,614.29% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $2.46 | +428.46% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.65 | +54.77% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $18.56 | -46.11% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $5.36 | +49.25% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $25.31 | +73.84% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $1.82 | +614.29% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $0.40 | +900.00% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.36 | +737.99% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $92.87 | +132.60% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $1.27 | +293.70% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.60 | +212.50% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $184.60 | -1.41% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $3.77 | +138.73% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $39.85 | +0.38% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $265.86 | +6.07% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $251.15 | -16.38% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $22.28 | +133.39% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $154.22 | +12.18% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $6.57 | +767.58% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $35.11 | +241.78% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $20.24 | +631.23% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $75.97 | +7.94% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $46.45 | +42.09% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.13 | +1,730.99% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $33.15 | +38.76% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $8.71 | +301.84% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $734.57 | -62.56% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $1.81 | +949.72% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $7.52 | +724.47% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $15.22 | +13.34% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $0.91 | +5,369.86% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $58.98 | +40.73% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $29.34 | +94.27% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $31.70 | -68.45% | 4 | Sep 10, 2018 |
Sarepta Therapeutics
May 7, 2025
Maintains: Overweight
Price Target: $182 → $113
Current: $36.27
Upside: +211.55%
Vertex Pharmaceuticals
May 6, 2025
Maintains: Equal-Weight
Price Target: $462 → $464
Current: $424.99
Upside: +9.18%
Gilead Sciences
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $96.91
Upside: +39.30%
Atea Pharmaceuticals
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $2.72
Upside: +120.59%
Biogen
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $157 → $152
Current: $118.17
Upside: +28.63%
Moderna
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $24.25
Upside: +31.96%
Legend Biotech
Mar 17, 2025
Maintains: Overweight
Price Target: $82 → $80
Current: $31.78
Upside: +151.73%
2seventy bio
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.99
Upside: +0.20%
Tenaya Therapeutics
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.41
Upside: +1,108.02%
Denali Therapeutics
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $14.37
Upside: +129.65%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $136.52
Upside: +30.38%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $36.80
Upside: +52.17%
Feb 6, 2025
Maintains: Overweight
Price Target: $85 → $90
Current: $65.08
Upside: +38.29%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $34.25
Upside: +60.58%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.17
Upside: +156.41%
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $527.78
Upside: +124.34%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.00
Upside: +500.00%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $12.30
Upside: -10.57%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.23
Upside: +550.41%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $549.27
Upside: -7.15%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.45
Upside: +382.76%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $58.86
Upside: +90.28%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $16.60
Upside: +104.82%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $19.36
Upside: +65.29%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $1.30
Upside: +1,361.54%
Jul 11, 2023
Reiterates: Underweight
Price Target: $60
Current: $3.50
Upside: +1,614.29%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $2.46
Upside: +428.46%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.65
Upside: +54.77%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $18.56
Upside: -46.11%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $5.36
Upside: +49.25%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $25.31
Upside: +73.84%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $1.82
Upside: +614.29%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $0.40
Upside: +900.00%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.36
Upside: +737.99%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $92.87
Upside: +132.60%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.27
Upside: +293.70%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.60
Upside: +212.50%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $184.60
Upside: -1.41%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $3.77
Upside: +138.73%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $39.85
Upside: +0.38%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $265.86
Upside: +6.07%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $251.15
Upside: -16.38%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $22.28
Upside: +133.39%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $154.22
Upside: +12.18%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $6.57
Upside: +767.58%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $35.11
Upside: +241.78%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $20.24
Upside: +631.23%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $75.97
Upside: +7.94%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $46.45
Upside: +42.09%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.13
Upside: +1,730.99%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $33.15
Upside: +38.76%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $8.71
Upside: +301.84%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $734.57
Upside: -62.56%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $1.81
Upside: +949.72%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $7.52
Upside: +724.47%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.22
Upside: +13.34%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $0.91
Upside: +5,369.86%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $58.98
Upside: +40.73%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $29.34
Upside: +94.27%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $31.70
Upside: -68.45%